Trials / Unknown
UnknownNCT02038621
The Maintenance Therapy of Capecitabine of Advanced Gastric Cancer
Phase II Clinical Study of the Maintenance Therapy of Capecitabine Afer the XELOX in Treatment of Advanced Gastric Cancer
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 224 (estimated)
- Sponsor
- The Second People's Hospital of Sichuan · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To confirm the efficacy and safety of XELOX with capecitabine maintenance in treatment of advanced gastric cancer (AGC)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Paclitaxel | |
| DRUG | Oxaliplatin and Capecitabine | Before randomization,all enrolled patients underwent 3 cycles XELOX chemotheray. After patients' disease achieved CR\\PR\\SD,then randomized into this clinical trial. |
Timeline
- Start date
- 2014-01-01
- Primary completion
- 2016-12-01
- Completion
- 2017-12-01
- First posted
- 2014-01-16
- Last updated
- 2014-01-16
Source: ClinicalTrials.gov record NCT02038621. Inclusion in this directory is not an endorsement.